121
Participants
Start Date
January 15, 2015
Primary Completion Date
December 15, 2017
Study Completion Date
March 28, 2019
Riociguat (Adempas, BAY63-2521)
Starting dose 0.5 mg TID, increase by 0.5 mg every 2 weeks until highest possible dose of 2.5 mg TID
Placebo
Sham-titration
CU Saint-Luc/UZ St-Luc, Bruxelles - Brussel
Liverpool Hospital, Liverpool
UZ Leuven Gasthuisberg, Leuven
St Vincent's Hospital, Fitzroy
Monash Medical Centre, Clayton
Debreceni Egyetem Klinikai Kozpont, Debrecen
Royal Adelaide Hospital, Adelaide
Royal Perth Hospital, Perth
Wellington Hospital, Wellington
Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs
UniversitätsSpital Zürich, Zurich
UZ Gent, Ghent
Kantonsspital St. Gallen, Sankt Gallen
Georgetown University Medical Center, Washington D.C.
Medical University of South Carolina Medical Center, Charleston
Hôpital Pellegrin - Bordeaux, Bordeaux
Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul
A.O. di Padova, Padua
Dokuz Eylul Universitesi Tip Fakultesi, Izmir
Centre Hospitalier Universitaire - Grenoble, Grenoble
University of Michigan Health System, Ann Arbor
A.O.U. Careggi, Florence
Universitätsklinikum Köln, Cologne
A.O.U. Pisana, Pisa
Hopital Claude-Huriez CHRU, Lille
Kerckhoff-Klinik GmbH, Bad Nauheim
CHU STRASBOURG - Hôpital de Hautepierre, Strasbourg
Cochin - Paris, Paris
Memorial Hermann-Texas Medical Center, Houston
University of Utah Health Care, Salt Lake City
Universitätsklinikum Ulm, Ulm
Universitätsklinikum Erlangen, Erlangen
Stanford University School of Medicine, Palo Alto
Mayo Clinic - Scottsdale, Scottsdale
UCLA David Geffen School of Medicine, Los Angeles
University of Connecticut Health Center, Farmington
Rutgers Robert Wood Johnson Medical School, New Brunswick
St. Joseph's Healthcare - Hamilton, Hamilton
Arthritis Program Research Group, Inc., Newmarket
Mount Sinai Hospital, Toronto
Sir Mortimer B. Davis Jewish General Hospital, Montreal
Revmatologicky ustav, Prague
A.O.U. Policlinico Umberto I, Rome
A.O.U. di Cagliari, Cagliari
Gunma University Hospital, Maebashi
Hokkaido University Hospital, Sapporo
Tohoku University Hospital, Sendai
Nippon Medical School Hospital, Bunkyo-ku
Institute of Rheumatology Tokyo Women's Medical University, Shinjuku-ku
Universitair Medisch Centrum St. Radboud, Nijmegen
University Medical Center Utrecht, Utrecht
Universitätsspital Basel, Basel
Hacettepe Universitesi Tip Fakultesi, Ankara
Cukurova Univ. Tip. Fak. Balcali Hastanesi, Adana
Hope Hospital, Salford
Freeman Hospital, Newcastle upon Tyne
Ninewells Hospital, Dundee
Aintree University Hospital, Liverpool
Royal Free Hospital, London
Lead Sponsor
Bayer
INDUSTRY